reduction of conjunctival bacterial flora with the use of mupirocin nasal ointment

15
Reduction Of Conjunctival Bacterial Flora With The Use Of Mupirocin Nasal Ointment Terry J. Alexandrou, MD Ophthalmology Resident The University of Chicago School of Medicine Department of Ophthalmology and Visual Science

Upload: eyedoc34

Post on 31-May-2015

2.337 views

Category:

Health & Medicine


1 download

DESCRIPTION

Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

TRANSCRIPT

Page 1: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Reduction Of Conjunctival BacterialFlora With The Use Of

Mupirocin Nasal Ointment

Terry J. Alexandrou, MDOphthalmology Resident

The University of Chicago School of Medicine

Department of Ophthalmology and Visual Science

Page 2: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Acknowledgements

• Seenu Hariprasad

• William F. Mieler

• Joseph Benevento

• Anthony Mazzulla

• Michael Saidel

• Susan Ksiazek

• Kenneth Thompson

• Sue Boonlayangoor

• Grant Support:

— Research to Prevent Blindness Foundation

Page 3: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Post-Cataract Surgery Endophthalmitis

• 94.2% of isolates gram-positives

(70% S. epidermidis)

Han DP, et al. Am J Ophthalmol. 1996;122(1):1-17.

Endophthalmitis Vitrectomy Study

24%70%

6%

Gram-positivecoagulase-negative

organisms (Staphylococcusepidermidis)

Gram-negativeorganisms

OtherGram-positive

organisms

Page 4: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Sources of Bacterial Contamination

• Gram-positive organisms are part of human normal flora

— Eyelids

— Eyelashes

— Conjunctiva

— Nasal Secretions

• Speaker and colleagues found that organisms isolated from the vitreous were genetically indistinguishable from those recovered from the eyelids, conjunctiva, or nose in 14 of 17 cases of endophthalmitis

Page 5: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Mupirocin(Bactroban®, Glaxo-Smith Kline)

• Antibacterial agent produced by fermentation using the organism Pseudomonas fluorescens. Acts by interfering with the action of isoleucyl-transfer RNA synthetase

• Mupirocin is active against gram positive organisms, including Staphylococcus and Streptococcus spp.

• Available as a nasal ointment, and is used for the eradication of methicillin-resistant S. aureus.

• Nasal carriage of S. aureus was eliminated in 91% of colonized healthcare workers 2 to 4 days following treatment with mupirocin ointment.

Mupirocin (Bactroban®) Ointment (C26H43O9)2Ca●2H20

Page 6: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Reduction of Surgical Site InfectionsEffectiveness of using Mupirocin: Non-Ophthalmic Literature

• Nasal carriage of gram positive organisms is a well established risk factor for surgical site infections (SSI).

— In a large multicenter study of S. aureus bacteremia, greater than 80% of the blood isolates were identical to those from the anterior nares.

• Kluytmans and collegues demonstrated that perioperative elimination of nasal carriage using mupirocin reduced SSI rate in cardiothoracic surgery patients

• The “Mupirocin Study Group” demonstrated that using mupirocin nasal ointment effectively reduced the incidence of S. aureus infections in hemodialysis and peritoneal dialysis patients

Page 7: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Reduction of Surgical Site InfectionsEffectiveness of using Mupirocin

•Can use of Mupirocin ointment to eliminate nasal bacterial carriage prior to intraocular surgery be effective in reducing conjunctival bacterial flora?

Page 8: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Methods

• Prospective, blinded, randomized clinical trial

• 42 patients undergoing elective Phaco/IOL or PPV

— 22 patients were enrolled in the control group and received no nasal medication

— 20 patients were enrolled in the treatment group and were asked to self-administer mupirocin ointment to each nostril twice daily for 5 days prior to surgery

A) B) C)

Page 9: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

MethodsCultures & Microbiology

• Nasal

— Obtained in all patients

— In treatment group, nasal cultures obtained prior to mupirocin administration.

• Conjunctival

— First before application of 5% povidone-iodine scrub

— Second immediately before surgery

— Care was taken to avoid touching the eyelid margin or lashes and patients did not received topical antibiotics prior to culture

• Microbiology

— Immediate innoculation on Columbia Agar with 5% Sheep Blood and Chocolate II Agar plates

— Plates were incubated overnight in 5-10% CO2

— Daily examination of plates until final report issued by blinded microbiologist

Page 10: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Results Nasal Cultures 100% Positive

9% S. Aureus (3 MRSA / 3 MSSA)

16% S. viridans

22% Corynebacterium 8% Others

45% Coag. Neg. Staph

Page 11: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Results Conjunctival Cultures

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

Before Povodine-Iodine Prep After Povodine-Iodine Prep

Control

Mupirocin

Page 12: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Discussion

• A significant reduction in conjunctival bacterial flora can be achieved with preoperative nasal application of mupirocin ointment

— Although the use of povidone-iodine is the “gold standard” for ocular surface sterilization, this reduction was observed with or without the use of povidone-iodine.

Page 13: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Discussion

• It has been proposed that nasal secretions may breach the sterile drape and contaminate the operative field*

• Kuhn and associates describe 2 cases of clear mucous nasal secretions reaccumulating on the conjunctiva during vitrectomy

• Studies underway to investigate this further

* Nagle F, Cooper RL. Nasal secretions in ocular surgery under general and local anesthesia. Ophthalmic Surg 1993;24:13-15.

Page 14: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Conclusions

• The goal of pre-operative prophylaxis of any type is to decrease the incidence of post-operative endophthalmitis

— Lower conjunctival contamination rates should theoretically reduce the incidence of postoperative endophthalmitis

• The use of mupirocin nasal ointment prior to intraocular surgery or intravitreal injections is a novel method for reducing conjunctival contamination rates

• Future studies will be needed to precisely define the role of mupirocin nasal ointment for the prophylaxis against intraocular infections

Page 15: Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment

Thank you for your attention